Novel Application of Steroid Eluting Stent in Petrous Apex Cholesterol Granuloma

Abstract

Objective This study describes the safety and efficacy of mometasone furoate eluting stents in the management of petrous apex cholesterol granuloma approached through an endonasal endoscopic route and assesses the restenosis rate.

Methods Consecutive patients undergoing endoscopic endonasal marsupialization of a petrous apex cholesterol granuloma at a tertiary referral center who had a mometasone furoate eluting stent placed intraoperatively were reviewed in a retrospective fashion. Postoperative endoscopy was used to determine success of surgery and stenting.

Results Five patients were included in the study, three were primary cases and two patients had revision surgeries performed. The steroid eluting stent was placed successfully and safely in all patients with no dural or vascular injuries. The average follow-up duration was 10.6 months. There was no restenosis in three patients and one patient had an immediate restenosis that was debrided in clinic (revision case). This was patent at the 16 months follow-up. One patient also developed stenosis, 4 months after surgery due to sphenoid sinusitis.

Conclusion Mometasone furoate eluting stents are safe and effective in the primary management of petrous apex cholesterol granuloma. Further studies are needed to assess their efficacy in revision cases and for long term results.

Keywords

cholesterol granuloma - steroid eluting stents - surgical techniques - endoscopic skull base surgery

Financial Disclosures

No relevant disclosures.

Poster Presentation

Poster presentation at the 2018 North American Skull Base Society Annual Meeting, Coronado, CA, U.S.A., February 17th, 2018.

• References

• 1 Fucci MJ, Alford EL, Lowry LD, Keane WM, Sataloff RT. Endoscopic management of a giant cholesterol cyst of the petrous apex. Skull Base Surg 1994; 4 (01) 52-58
• 2 Aubry K, Kania R, Sauvaget E, Huy PT, Herman P. Endoscopic transsphenoidal approach to petrous apex cholesteatoma. Skull Base 2010; 20 (04) 305-308
• 3 Jaberoo MC, Hassan A, Pulido MA, Saleh HA. Endoscopic endonasal approaches to management of cholesterol granuloma of the petrous apex. Skull Base 2010; 20 (05) 375-379
• 4 Eisenberg MB, Haddad G, Al-Mefty O. Petrous apex cholesterol granulomas: evolution and management. J Neurosurg 1997; 86 (05) 822-829
• 5 Georgalas C, Kania R, Guichard JP, Sauvaget E, Tran Ba Huy P, Herman P. Endoscopic transsphenoidal surgery for cholesterol granulomas involving the petrous apex. Clin Otolaryngol 2008; 33 (01) 38-42
• 6 Samadian M, Vazirnezami M, Moqaddasi H, Rakhshan M, Khormaee F, Ashraf H. Endoscopic transrostral-transsphenoidal approach to petrous apex cholesterol granuloma: case report. Turk Neurosurg 2009; 19 (01) 106-111
• 7 Shibao S, Toda M, Tomita T. , et al. Petrous apex cholesterol granuloma: importance of pedicled nasoseptal flap in addition to silicone T-tube for prevention of occlusion of drainage route in transsphenoidal approach--a technical note. Neurol Med Chir (Tokyo) 2015; 55 (04) 351-355
• 8 Forwith KD, Han JK, Stolovitzky JP. , et al. RESOLVE: bioabsorbable steroid-eluting sinus implants for in-office treatment of recurrent sinonasal polyposis after sinus surgery: 6-month outcomes from a randomized, controlled, blinded study. Int Forum Allergy Rhinol 2016; 6 (06) 573-581
• 9 Han JK, Forwith KD, Smith TL. , et al. RESOLVE: a randomized, controlled, blinded study of bioabsorbable steroid-eluting sinus implants for in-office treatment of recurrent sinonasal polyposis. Int Forum Allergy Rhinol 2014; 4 (11) 861-870
• 10 Santarelli GD, Han JK. Evaluation of the PROPEL^® mini sinus implant for the treatment of frontal sinus disease. Expert Opin Drug Deliv 2016; 13 (12) 1789-1793
• 11 Eytan DF, Kshettry VR, Sindwani R, Woodard TD, Recinos PF. Surgical outcomes after endoscopic management of cholesterol granulomas of the petrous apex: a systematic review. Neurosurg Focus 2014; 37 (04) E14
• 12 Smith TL, Singh A, Luong A. , et al. Randomized controlled trial of a bioabsorbable steroid-releasing implant in the frontal sinus opening. Laryngoscope 2016; 126 (12) 2659-2664